Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Keros Therapeutics (KROS) Preferred Shares Issued (2020)

Historic Preferred Shares Issued for Keros Therapeutics (KROS) over the last 1 years, with Q1 2020 value amounting to $56.0 million.

  • Keros Therapeutics' Preferred Shares Issued changed N/A to $56.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was $56.0 million, marking a year-over-year change of. This contributed to the annual value of $56.0 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q1 2020, Keros Therapeutics' Preferred Shares Issued is $56.0 million.
  • Keros Therapeutics' 5-year Preferred Shares Issued high stood at $56.0 million for Q1 2020, and its period low was $56.0 million during Q1 2020.